Literature DB >> 8458645

Estrogen receptor variant and hypertension in women.

S Lehrer1, J Rabin, T Kalir, B S Schachter.   

Abstract

Eighty-eight women visiting a gynecologist were tested for an estrogen receptor B-variant allele. The women were ethnically and racially homogeneous to a large degree. They were from a suburb of Long Island, and most were white. The 12% incidence of hypertension in women with the estrogen receptor wild-type allele is comparable to the 13-32% incidence in the general population of women aged 55-64 years. However, the 48% incidence of hypertension in women with the estrogen receptor B-variant allele is considerably higher than in the general population of women in this age group. We conclude that the presence of the estrogen receptor B-variant allele might have increased the prevalence of hypertension in the women in this study.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458645     DOI: 10.1161/01.hyp.21.4.439

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Meta-analysis of hypertension and osteoporotic fracture risk in women and men.

Authors:  C Li; Y Zeng; L Tao; S Liu; Z Ni; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2017-04-26       Impact factor: 4.507

2.  Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis.

Authors:  T Ushiyama; K Mori; K Inoue; J Huang; J Nishioka; S Hukuda
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

3.  The role of osteoprotegerin (OPG) and estrogen receptor (ER-α) gene polymorphisms in rheumatoid arthritis.

Authors:  Laura Masi; Susanna Maddali Bongi; Chiara Angotti; Francesca Del Monte; Silvia Carbonell Sala; Massimo Basetti; Antonietta Amedei; Alberto Falchetti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

4.  Analysis of sex hormone genes reveals gender differences in the genetic etiology of blood pressure salt sensitivity: the GenSalt study.

Authors:  Tanika N Kelly; Casey M Rebholz; Dongfeng Gu; James E Hixson; Treva K Rice; Jie Cao; Jichun Chen; Jianxin Li; Fanghong Lu; Jixiang Ma; Jianjun Mu; Paul K Whelton; Jiang He
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

5.  Estrogen receptor alpha gene analysis in osteoporosis and familial osteoporosis.

Authors:  L Fountas; M Anapliotou; A Kominakis; C E Sekeris; E Kassi; P Moutsatsou
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

6.  Association of estrogen receptor alpha gene polymorphisms with cytokine genes expression in systemic lupus erythematosus.

Authors:  Zhi-Ming Lu; Zi-E Wang; Yi-Qing Liu; Chun-Xiao Wu; Chang-Yin Wang; Bing-Chang Zhang; Song Shao; Yu-Lian Jiao; Zhi-Xiang Che; Zi-Jiang Chen; Yue-Ran Zhao
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

7.  Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations.

Authors:  Masahiro Sasaki; Yuichiro Tanaka; Noriaki Sakuragi; Rajvir Dahiya
Journal:  Eur J Clin Pharmacol       Date:  2003-08-16       Impact factor: 2.953

8.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.

Authors:  D B Lubahn; J S Moyer; T S Golding; J F Couse; K S Korach; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

9.  Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India.

Authors:  Jayashri Ghosh; Gunjan Joshi; Sunil Pradhan; Balraj Mittal
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

10.  Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance.

Authors:  A J Desai; Y A Luqmani; J E Walters; R C Coope; B Dagg; J J Gomm; P E Pace; C N Rees; V Thirunavukkarasu; S Shousha; N P Groome; R Coombes; S Ali
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.